Results 71 to 80 of about 2,707 (130)

Developmental Toxicity Assessment of Piperonyl Butoxide Exposure Targeting Sonic Hedgehog Signaling and Forebrain and Face Morphogenesis in the Mouse: An in Vitro and in Vivo Study. [PDF]

Environ Health Perspect, 2019
Everson JL, Sun MR, Fink DM, Heyne GW, Melberg CG, Nelson KF, Doroodchi P, Colopy LJ, Ulschmid CM, Martin AA, McLaughlin MT, Lipinski RJ.   +11 more
europepmc   +1 more source

Sulfoxaflor and Natural Pyrethrin with Piperonyl Butoxide Are Effective Alternatives to Neonicotinoids against Juveniles of Philaenus spumarius, the European Vector of Xylella fastidiosa. [PDF]

Insects, 2019
Dáder B, Viñuela E, Moreno A, Plaza M, Garzo E, Del Estal P, Fereres A.   +6 more
europepmc   +1 more source

Synergist piperonyl butoxide enhances the efficacy of deltamethrin in deltamethrin-resistant Anopheles culicifacies sensu lato in malaria endemic districts of Odisha State, India. [PDF]

Indian J Med Res, 2019
Sahu SS, Dash S, Sonia T, Gunasekaran K.
europepmc   +1 more source

Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign.

Lancet, 2020
Staedke SG, Gonahasa S, Dorsey G, Kamya MR, Maiteki-Sebuguzi C, Lynd A, Katureebe A, Kyohere M, Mutungi P, Kigozi SP, Opigo J, Hemingway J, Donnelly MJ.   +12 more
europepmc   +1 more source

Widespread restoration to susceptibility in pyrethroid-resistant malaria vector Anopheles gambiae complex following pre-exposure to piperonyl-butoxide: results from country-wide insecticide resistance monitoring in Tanzania, 2023

Kabula B, Mlacha YP, Serbantez N, Nhiga SL, Mkude S, Kiware S, Michael J, Mero V, Ballard S, Chan A, Abbas S, Mwalimu CD, Govella NJ.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Metabolism and excretion of piperonyl butoxide in the rat

Xenobiotica, 2006
[14C]-piperonyl butoxide (PBO) was administered to male and female rats by gavage at a dose rate of 50 or 500 mg kg-1 body weight. In all cases, the radioactivity was rapidly excreted with 87-99% being found in the 0-48-h excreta and the majority of the dose (64.1-85.0%) being eliminated in faeces.
J, Byard, D, Needham
exaly   +3 more sources

Oncogenicity studies of piperonyl butoxide in rats and mice

Human and Experimental Toxicology, 1998
1 The oncogenicity of Piperonyl butoxide (PBO) has been studied in the mouse and rat. CD-1 mice were administered PBO in the diet at target doses of 0, 30, 100 and 300 mg/kg/day for 79 weeks and Sprague - Dawley rats 0, 30, 100 and 500 mg/kg/day for 104/105 weeks.
W H, Butler, K L, Gabriel, T G, Osimitz, F J, Preiss   +3 more
exaly   +3 more sources

Behavioural effects of piperonyl butoxide in male mice

Toxicology Letters, 1993
Piperonyl butoxide was administered to male mice from 5 to 12 weeks of age in the diet at levels of 0 (control), 0.15, 0.30, and 0.60%, and some behavioural parameters were measured. The animals performed three trials in multiple water T-maze at 10 weeks of age, and the number of errors was significantly decreased in treatment groups on the 3rd trial ...
Toyohito Tanaka
exaly   +3 more sources

Subacute toxicity of piperonyl butoxide in ICR mice

Toxicology, 1993
Piperonyl butoxide, alpha-[2-(2-butoxyethoxy)ethoxy]-4,5-methylenedioxy-2-propyltol uene, is a pesticide synergist. ICR mice of both sexes were maintained on diet containing 0, 0.1, 0.3 or 0.9% of piperonyl butoxide for 20 days. At the end of the experimental period, they were necropsied. Selected organs were weighed and serum chemistries were analyzed.
T Fujitani
exaly   +3 more sources

Piperonyl butoxide

Nader Rahimi Kakavandi, Tayebeh Asadi, Hojatollah Kakaei   +2 more
exaly   +3 more sources